The drug firm challenging the US omega-3 dietary supplement market in a fair trade complaint admits that FDA finds the products entirely compliant with its regulations and makes a repeatedly dismissed argument for its false advertising claim, says the Council for Responsible Nutrition.
In comments its attorneys submitted Sept. 14 to the International Trade Commission, the trade group also recommended the Department of...








